A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms

Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)

NCT00533481 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects

NCT01719419 ·Status: WITHDRAWN ·Phase: NA

Study of Fat Malabsorption by Lipiblock Versus Xenical

NCT01170806 ·Status: COMPLETED ·Phase: NA

Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults

NCT02706067 ·Status: COMPLETED ·Phase: PHASE4

Survey on the Pharmacy Follow-up of Alli Purchasers

NCT01387243 ·Status: COMPLETED

A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese

NCT05677867 ·Status: COMPLETED ·Phase: PHASE1

A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.

NCT01195792 ·Status: COMPLETED ·Phase: PHASE2

A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight

NCT06824051 ·Status: COMPLETED ·Phase: PHASE1

Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

NCT00991926 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

NCT04707313 ·Status: COMPLETED ·Phase: PHASE2

Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects

NCT00909766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Orlistat/Phentermine Versus Placebo/Phentermine

NCT03675191 ·Status: COMPLETED ·Phase: NA

Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

NCT00479492 ·Status: COMPLETED ·Phase: PHASE2

A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss

NCT00108524 ·Status: COMPLETED ·Phase: NA

Individualized Obesity Pharmacotherapy

NCT03374956 ·Status: COMPLETED ·Phase: PHASE3

STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY

NCT04616339 ·Status: COMPLETED ·Phase: PHASE1

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

NCT01126970 ·Status: COMPLETED ·Phase: PHASE2

RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.

NCT07301437 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study to Test Different Doses of BI 456906 in Patients With Obesity

NCT03591718 ·Status: COMPLETED ·Phase: PHASE1

Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

NCT06662539 ·Status: COMPLETED ·Phase: PHASE2

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

NCT03661879 ·Status: COMPLETED ·Phase: PHASE1

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine

NCT01184560 ·Status: COMPLETED ·Phase: NA

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

NCT00449202 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects

NCT01597609 ·Status: COMPLETED ·Phase: PHASE1

Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

NCT03308721 ·Status: COMPLETED ·Phase: PHASE1